IP Verse

Instone, Terry/read, Howard Graham/appleyard Lees Ip Llp opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol

Applicant:

Opposition Date:

Aug 17, 2022

Patent Number:

Title:

Sustained Release Formulations Using Non-Aqueous Carriers

Applicant:

Opposition Date:

Jan 28, 2021

Patent Number:

Title:

Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters

Applicant:

Opposition Date:

Dec 1, 2020

Patent Number:

Title:

Pharmaceutical Compositions Having Desirable Bioavailability

Applicant:

Opposition Date:

Feb 1, 2018

Patent Number	Title	Applicant	Opposition Date
EP3210965	Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol	GRÜNENTHAL GMBH	Aug 17, 2022
EP2341905	Sustained Release Formulations Using Non-Aqueous Carriers	AMYLIN PHARMACEUTICALS, INC.	Jan 28, 2021
EP3280416	Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICALS, INC.	Dec 1, 2020
EP3042646	Pharmaceutical Compositions Having Desirable Bioavailability	ALCON RESEARCH, LTD.	Feb 1, 2018

ALCON RESEARCH, LTD.

AMYLIN PHARMACEUTICALS, INC.

AMYLIN PHARMACEUTICALS, LLC

Feel free to send us a message here and we will get back to you